{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:25:29Z","timestamp":1791516329284,"version":"4.3.4"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/ibd\/izy247","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T11:57:54Z","timestamp":1533556674000},"page":"1-13","source":"Crossref","is-referenced-by-count":98,"title":["Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn\u2019s Disease: The Toronto Consensus"],"prefix":"10.1093","volume":"25","author":[{"given":"A Hillary","family":"Steinhart","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Panaccione","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Targownik","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bressler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, St Paul\u2019s Hospital, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"Marshall","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqqas","family":"Afif","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bitton","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Borgaonkar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Memorial University, St John\u2019s, Newfoundland, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Halloran","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios I","family":"Leontiadis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Edward V","family":"Loftus","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Meddings","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Murthy","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Plamondon","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Rosenfeld","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Pacific Gastroenterology Associates, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Vanderbilt University, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia H","family":"Seow","sequence":"additional","affiliation":[{"name":"Departments of Medicine & Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadwick","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Digestive Care & Endoscopy, Department of Medicine, Dartmouth General Hospital, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"key\n\t\t\t\t2019010312184044400_CIT0001","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted county, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1053\/j.gastro.2005.12.019","article-title":"Predictors of Crohn\u2019s disease","volume":"130","author":"Beaugerie","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0003","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/00365520801957149","article-title":"Predictors of severe Crohn\u2019s disease","volume":"43","author":"Loly","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0004","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3748\/wjg.v18.i29.3806","article-title":"Clinical, serological and genetic predictors of inflammatory bowel disease course","volume":"18","author":"Beaugerie","year":"2012","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0005","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","article-title":"Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn\u2019s perineal fistulas","volume":"104","author":"Ng","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0006","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0007","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/MIB.0000000000000315","article-title":"Guidelines for the multidisciplinary management of Crohn\u2019s perianal fistulas: summary statement","volume":"21","author":"Schwartz","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0008","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","article-title":"A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn\u2019s disease","volume":"63","author":"Gecse","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0009","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Bmj"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2013.02.001","article-title":"The AGA institute process for developing clinical practice guidelines part one: grading the evidence","volume":"11","author":"Sultan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0011","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1053\/j.gastro.2015.03.001","article-title":"Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the toronto consensus","volume":"148","author":"Bressler","year":"2015","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0012","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0013","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0014","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0016-3287(69)80025-X","article-title":"An experimental study of group opinion: the Delphi method","volume":"1","author":"Dalkey","year":"1969","journal-title":"Futures"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-127-3-199708010-00006","article-title":"The relation between systematic reviews and practice guidelines","volume":"127","author":"Cook","year":"1997","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0017","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bjs.1800630102","article-title":"A classification of fistula-in-ano","volume":"63","author":"Parks","year":"1976","journal-title":"Br J Surg"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/apt.13276","article-title":"Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy","volume":"42","author":"Gisbert","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0020","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/ibd.21933","article-title":"High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn\u2019s disease: a marker for patient classification","volume":"18","author":"Kiss","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0021","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/ibd.22861","article-title":"Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies","volume":"18","author":"Mao","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0022","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1097\/MIB.0000000000000894","article-title":"High vitamin D-binding protein concentration, low albumin, and mode of remission predict relapse in Crohn\u2019s disease","volume":"22","author":"Ghaly","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0023","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.12659\/MSM.897460","article-title":"Serum albumin and C-reactive protein\/albumin ratio are useful biomarkers of Crohn\u2019s disease activity","volume":"22","author":"Qin","year":"2016","journal-title":"Med Sci Monit"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0024","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","article-title":"Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn\u2019s disease","volume":"98","author":"Van Assche","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.MIB.0000172811.57242.18","article-title":"Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn\u2019s perianal fistulas","volume":"11","author":"Schwartz","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0026","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cgh.2010.10.022","article-title":"Long-term monitoring of infliximab therapy for perianal fistulizing Crohn\u2019s disease by using magnetic resonance imaging","volume":"9","author":"Karmiris","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0027","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/gast.2001.28676","article-title":"A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn\u2019s perianal fistulas","volume":"121","author":"Schwartz","year":"2001","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0028","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1111\/j.1572-0241.2008.02063.x","article-title":"A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn\u2019s perianal fistulas","volume":"103","author":"Spradlin","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0029","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/MIB.0000000000000409","article-title":"Use of endoscopic ultrasound to guide adalimumab treatment in perianal Crohn\u2019s disease results in faster fistula healing","volume":"21","author":"Wiese","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0030","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ejrad.2011.01.046","article-title":"Role of magnetic resonance imaging in evaluation of the activity of perianal Crohn\u2019s disease","volume":"81","author":"Villa","year":"2012","journal-title":"Eur J Radiol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0031","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 2: surgical management and special situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0032","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/DCR.0000000000000244","article-title":"Accuracy of CT enterography and magnetic resonance enterography imaging to detect lesions preoperatively in patients undergoing surgery for Crohn\u2019s disease","volume":"57","author":"Seastedt","year":"2014","journal-title":"Dis Colon Rectum"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0033","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1572-0241.2003.07521.x","article-title":"Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn\u2019s disease: a prospective comparative study","volume":"98","author":"Maconi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0034","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/apt.12906","article-title":"Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn\u2019s disease","volume":"40","author":"Yassin","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ajg.2011.72","article-title":"Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0036","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","article-title":"Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI)","volume":"63","author":"Dewint","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0037","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1751-2980.12216","article-title":"Use of antibiotics in patients with Crohn\u2019s disease: a systematic review and meta-analysis","volume":"16","author":"Su","year":"2015","journal-title":"J Dig Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0038","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2036.2004.02247.x","article-title":"Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn\u2019s disease with infliximab: a double-blind placebo-controlled study","volume":"20","author":"West","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0039","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0040","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gut.2008.159251","article-title":"Adalimumab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"58","author":"Colombel","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0041","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human antitumor necrosis factor monoclonal antibody (adalimumab) in Crohn\u2019s disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0042","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","article-title":"Adalimumab induction therapy for crohn disease previously treated with infliximab: a randomized trial","volume":"146","author":"Sandborn","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0043","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa067594","article-title":"Certolizumab pegol for the treatment of Crohn\u2019s disease","volume":"357","author":"Sandborn","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0044","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajg.2011.73","article-title":"Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0045","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/codi.13311","article-title":"Treatment of perianal fistula in Crohn\u2019s disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment","volume":"18","author":"de Groof","year":"2016","journal-title":"Colorectal Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0046","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0047","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa062897","article-title":"Maintenance therapy with certolizumab pegol for Crohn\u2019s disease","volume":"357","author":"Schreiber","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0048","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2036.2010.04509.x","article-title":"Randomised clinical trial: certolizumab pegol for fistulas in Crohn\u2019s disease - subgroup results from a placebo-controlled study","volume":"33","author":"Schreiber","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0049","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/j.gastro.2005.01.048","article-title":"Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn\u2019s disease","volume":"128","author":"Lichtenstein","year":"2005","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0050","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/apt.12499","article-title":"Adalimumab maintains remission of Crohn\u2019s disease after up to 4 years of treatment: data from CHARM and ADHERE","volume":"38","author":"Panaccione","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0051","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ibd.21405","article-title":"Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn\u2019s disease: results from a prospective study","volume":"17","author":"Roumegu\u00e8re","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0052","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10350-004-6611-4","article-title":"Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn\u2019s disease: a single center experience","volume":"46","author":"Topstad","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0053","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2036.2004.01850.x","article-title":"Combining infliximab and methotrexate in fistulizing Crohn\u2019s disease resistant or intolerant to azathioprine","volume":"19","author":"Schr\u00f6der","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0054","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.2002.05918.x","article-title":"Combining infliximab with 6-mercaptopurine\/azathioprine for fistula therapy in Crohn\u2019s disease","volume":"97","author":"Ochsenk\u00fchn","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0055","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/ibd.21940","article-title":"Long-term MRI-guided combined anti-TNF-\u03b1 and thiopurine therapy for Crohn\u2019s perianal fistulas","volume":"18","author":"Tozer","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0056","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","article-title":"Long-term outcome of perianal fistulizing Crohn\u2019s disease treated with infliximab","volume":"11","author":"Bouguen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0057","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn\u2019s disease with 6-mercaptopurine. A long-term, randomized, double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0058","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0059","first-page":"549","article-title":"Association of induction infliximab levels with clinical response in perianal Crohn\u2019s disease","volume":"11","author":"Davidov","year":"2017","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/apt.13970","article-title":"Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn\u2019s disease","volume":"45","author":"Yarur","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0061","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1463-1318.2009.01811.x","article-title":"Seton drainage and fibrin glue injection for complex anal fistulas","volume":"12","author":"de Parades","year":"2010","journal-title":"Colorectal Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0062","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/DCR.0b013e3181b72378","article-title":"Outcomes after fistulotomy: results of a prospective, multicenter regional study","volume":"52","author":"Hyman","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0063","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/codi.13106","article-title":"Long-term outcome after surgery for Crohn\u2019s anal fistula","volume":"18","author":"Graf","year":"2016","journal-title":"Colorectal Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0064","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/codi.13268","article-title":"The anal fistula plug in Crohn\u2019s disease patients with fistula-in-ano: a systematic review","volume":"18","author":"Nasseri","year":"2016","journal-title":"Colorectal Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ecco-jcc\/jjv162","article-title":"Fistula plug in fistulising ano-perineal Crohn\u2019s disease: a randomised controlled trial","volume":"10","author":"Sen\u00e9joux","year":"2016","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0066","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/DCR.0b013e3181ce8b01","article-title":"Endorectal advancement flap for cryptoglandular or Crohn\u2019s fistula-in-ano","volume":"53","author":"Soltani","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0067","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/SLA.0000000000000479","article-title":"A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn\u2019s disease","volume":"260","author":"Gingold","year":"2014","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0068","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/apt.13356","article-title":"Systematic review with meta-analysis: faecal diversion for management of perianal Crohn\u2019s disease","volume":"42","author":"Singh","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0069","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijsu.2015.12.005","article-title":"Influence of diversion stoma on surgical outcome and recurrence rates in patients with rectovaginal fistula - A retrospective cohort study","volume":"25","author":"Lambertz","year":"2016","journal-title":"Int J Surg"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0070","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2036.2003.01561.x","article-title":"The clinical course of fistulating Crohn\u2019s disease","volume":"17","author":"Bell","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0071","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0072","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/MIB.0000000000000842","article-title":"Ustekinumab for the treatment of refractory Crohn\u2019s disease: the Spanish experience in a large multicentre open-label cohort","volume":"22","author":"Khorrami","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0073","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.crohns.2014.06.005","article-title":"Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn\u2019s disease\u2013the McGill experience","volume":"8","author":"Kopylov","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0074","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00054725-199911000-00001","article-title":"Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn\u2019s disease perianal fistulae","volume":"5","author":"Lowry","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200501000-00002","article-title":"Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn\u2019s disease: a pilot study","volume":"11","author":"Gonz\u00e1lez-Lama","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0076","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0016-5085(03)00877-1","article-title":"Tacrolimus for the treatment of fistulas in patients with Crohn\u2019s disease: a randomized, placebo-controlled trial","volume":"125","author":"Sandborn","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0077","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ibd.20073","article-title":"Topical tacrolimus in the treatment of perianal Crohn\u2019s disease: exploratory randomized controlled trial","volume":"13","author":"Hart","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0078","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0079","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ecco-jcc\/jjx002.008","article-title":"Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn\u2019s disease: 52-week results of a phase III randomised controlled trial [Abstract OP009]","volume":"11","author":"Panes","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1572-0241.1999.00848.x","article-title":"Hyperbaric oxygen therapy for perineal Crohn\u2019s disease","volume":"94","author":"Noyer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0081","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0102-86502011000800024","article-title":"Crohn\u2019s disease and hyperbaric oxygen therapy","volume":"26","author":"Iezzi","year":"2011","journal-title":"Acta Cir Bras"},{"key":"key\n\t\t\t\t2019010312184044400_CIT0082","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1590\/S0102-86502016001300005","article-title":"Adjunctive hyperbaric oxygen therapy promotes successful healing in patients with refractory Crohn\u2019s disease","volume":"31","author":"Feitosa","year":"2016","journal-title":"Acta Cir Bras"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/25\/1\/1\/27375656\/izy247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T18:16:13Z","timestamp":1571681773000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/25\/1\/1\/5067389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,8,6]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izy247","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,8,6]]}}}